A groundbreaking drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

A new medicine, discovered by scientists, protects nerve cells damaged by motor neurone disease (MND), offering hope of substantially slowing the progression of "one of the cruellest diseases".

Changes in motor units closely reflect disease severity in people with spinal muscular atrophy (SMA), suggesting potential ...

A discovery that may improve treatment options for patients with neurodegenerative diseases. A discovery that may improve treatment options for patients with neurodegenerative diseases has been made ...

Scientists have traced connectivity between neurons to identify how the brain communicates with the spinal cord. A new brain map visualizes the connections between the brain and spinal cord at the ...

SMA type 2, previously known as Dubowitz disease, is a hereditary disease that affects motor neurons. It typically becomes noticeable around the ages of 6 to 18 months, when children with the ...

Primary lateral sclerosis (PLS) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases. PLS typically develops slowly, while ALS rapidly affects mobility and can become fatal.

The test was developed by researchers at the US-based not-for-profit Brain Chemistry Labs, who analysed 788 blood samples – roughly half from patients with the disease and half from people without it.